<html>
<head>PUBMED IDs for HAI-2</head>
<body bgcolor='#C5F0F2'><h1>HAI-2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10049781/'>Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human.</a> March 2  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10824123/'>Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes.</a> May 29  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11406276/'>Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters.</a> June 19  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11562767/'>Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.</a> September 20  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11606055/'>Identification of hepatocyte growth factor activator inhibitor type 2 (HAI-2)-related small peptide (H2RSP): its nuclear localization and generation of chimeric mRNA transcribed from both HAI-2 and H2RSP genes.</a> October 19  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12553733/'>Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis.</a> January 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12604353/'>Characterization of transcripts generated from mouse hepatocyte growth factor activator inhibitor type 2 (HAI-2) and HAI-2-related small peptide (H2RSP) genes: chimeric mRNA transcribed from both HAI-2 and H2RSP genes is detected in human but not in mouse.</a> February 27  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14558597/'>Differential expression of bikunin (HAI-2/PB), a proposed mediator of glioma invasion, by demethylation treatment.</a> October 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14695180/'>Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.</a> December 26  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15839837/'>Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers.</a> April 21  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15930277/'>Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.</a> June 3  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16557597/'>Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.</a> March 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18195710/'>Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma.</a> January 16  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18713750/'>Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.</a> August 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18816607/'>Hepatocyte growth factor (HGF) and the satellite cell response following muscle lengthening contractions in humans.</a> September 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19047176/'>An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.</a> December 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19107935/'>HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions.</a> March 20  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20664929/'>Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are potential targets in uterine leiomyosarcoma.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21896084/'>Gastric cancer: basic aspects.</a> December 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23293962/'>Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2.</a> April 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23293949/'>Case of hypohidrotic ectodermal dysplasia caused by a large deletion mutation in the EDA gene.</a> February 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24121274/'>HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.</a> November 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24722141/'>Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.</a> January 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24962579/'>The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.</a> February 20  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25786220/'>Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.</a> February 6  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26030814/'>Aberrant methylation of promoter region of SPINT2/HAI-2 gene: an epigenetic mechanism in hepatitis C virus-induced hepatocarcinogenesis.</a> May 28  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26171609/'>N-Glycan Branching Affects the Subcellular Distribution of and Inhibition of Matriptase by HAI-2/Placental Bikunin.</a> April 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28094766/'>Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis.</a> January 18  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28094758/'>Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts.</a> January 18  2017<br></body></html>
